Search - tctmd.com

Displaying 241 - 260 of 343

Sort: Relevancy | Date

Presentation TCT 2015

CTO PCI in Patients With ACS and Multivessel Disease

Presenter: R. Michael Wyman, Renato Valenti

October 12, 2015

Presentation TCT 2015

Physiological Assessment in Multivessel Disease: What Will SYNTAX 2 and FAME 3 Tell Us?

Presenter: Sergio B Baptista, Eric Van Belle, Bernard De Bruyne

October 12, 2015

Presentation TCT 2015

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Presenter: Morton J. Kern, Jan J. Piek, Javier Escaned

October 12, 2015

Presentation TCT 2015

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Expedito E. Ribeiro

October 11, 2015

Presentation TCT 2015

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Minh Vo

October 11, 2015

Presentation TCT 2015

PCI for Multivessel Disease With CTO: When and How? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Cheol Woong Yu

October 11, 2015

Presentation TCT 2015

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Kevin Bainey

October 11, 2015

Presentation TCT 2015

How to Apply Physiology-Guided PCI for MVD

Presenter: Thomas Engstroem, Manh-Hung Pham, Chang-Wook Nam

October 11, 2015

Presentation TCT 2015

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Presenter: Thomas Engstroem, Manh-Hung Pham, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Complete vs Incomplete Revascularization

Presenter: Thomas Engstroem, Manh-Hung Pham, David A. Wood

October 11, 2015

Presentation TCT 2015

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Presenter: Taehoon Ahn, Robert C. Welsh, Young-Hak Kim

October 11, 2015

Presentation TCT 2015

Outcomes Have Always Been Better With CABG

Presenter: Taehoon Ahn, Robert C. Welsh, Samer Mansour

October 11, 2015

Presentation TCT 2015

Current Guideline Update

Presenter: Taehoon Ahn, Robert C. Welsh, Manh-Hung Pham

October 11, 2015

Presentation TCT 2015

Case Resolution: How Did We Treat Our STEMI Patient With Multivessel Disease (and What Were the Long-term Outcomes)?

Presenter: Thomas Engstroem, Barry D. Rutherford, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Case Introduction: A STEMI Patient With Multivessel Disease

Presenter: Thomas Engstroem, Barry D. Rutherford, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Antoniucci

October 11, 2015

Presentation TCT 2015

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Erlinge

October 11, 2015

Presentation TCT 2015

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Presenter: Thomas Engstroem, Barry D. Rutherford, Colin Berry

October 11, 2015

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Advertisement

CTO PCI in Patients With ACS and Multivessel Disease

Physiological Assessment in Multivessel Disease: What Will SYNTAX 2 and FAME 3 Tell Us?

Spain Presents: A Case of iFR-FFR to Guide Coronary Revascularization in Multivessel Disease

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

PCI for Multivessel Disease With CTO: When and How? With Case Examples

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

How to Apply Physiology-Guided PCI for MVD

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Complete vs Incomplete Revascularization

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Outcomes Have Always Been Better With CABG

Current Guideline Update

Case Resolution: How Did We Treat Our STEMI Patient With Multivessel Disease (and What Were the Long-term Outcomes)?

Case Introduction: A STEMI Patient With Multivessel Disease

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content